These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6827905)

  • 1. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.
    Cohen ML; Fuller RW
    Life Sci; 1983 Feb; 32(7):711-8. PubMed ID: 6827905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.
    Cohen ML; Fuller RW; Wiley KS
    J Pharmacol Exp Ther; 1981 Aug; 218(2):421-5. PubMed ID: 7252841
    [No Abstract]   [Full Text] [Related]  

  • 4. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.
    Fuller RW; Kurz KD; Mason NR; Cohen ML
    Eur J Pharmacol; 1986 Jun; 125(1):71-7. PubMed ID: 3732393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
    McKearney JW
    Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence that the serotonin receptor in the rat stomach fundus is not 5HT1A or 5HT1B.
    Cohen ML; Wittenauer LA
    Life Sci; 1986 Jan; 38(1):1-5. PubMed ID: 3941588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.
    Robertson DW; Bloomquist W; Wong DT; Cohen ML
    Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.
    Leff P; Martin GR; Morse JM
    Br J Pharmacol; 1987 Jun; 91(2):321-31. PubMed ID: 3607360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).
    Kłodzińska A; Jaros T; Chojnacka-Wójcik E; Maj J
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):207-18. PubMed ID: 2775468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of trazodone with serotonin neurons and receptors.
    Fuller RW; Snoddy HD; Cohen ML
    Neuropharmacology; 1984 May; 23(5):539-44. PubMed ID: 6429562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities.
    Cohen ML; Johnson MP; Schenck KW; Susemichel A; Wainscott DB; Robertson DW; Nelson DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):943-9. PubMed ID: 8355216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5HT2 receptors in the rat portal vein: desensitization following cumulative serotonin addition.
    Lemberger HF; Mason N; Cohen ML
    Life Sci; 1984 Jul; 35(1):71-7. PubMed ID: 6738305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-releasing effects of substituted piperazines in vitro.
    Pettibone DJ; Williams M
    Biochem Pharmacol; 1984 May; 33(9):1531-5. PubMed ID: 6610423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein.
    Ellis ES; Byrne C; Murphy OE; Tilford NS; Baxter GS
    Br J Pharmacol; 1995 Jan; 114(2):400-4. PubMed ID: 7881740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.
    Humphrey PP; Feniuk W; Perren MJ; Connor HE; Oxford AW; Coates LH; Butina D
    Br J Pharmacol; 1988 Aug; 94(4):1123-32. PubMed ID: 2850055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.